CytomX Therapeutics (CTMX) Short Interest Ratio & Short Volume → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free CTMX Stock Alerts $2.00 +0.04 (+2.04%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability CytomX Therapeutics Short Interest DataCurrent Short Volume3,600,000 sharesPrevious Short Volume3,590,000 sharesChange Vs. Previous Month+0.28%Dollar Volume Sold Short$5.87 millionShort Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares77,920,000 sharesPercentage of Shares Shorted4.62%Today's Trading Volume3,277,447 sharesAverage Trading Volume4,447,426 sharesToday's Volume Vs. Average74% Short Selling CytomX Therapeutics ? Sign up to receive the latest short interest report for CytomX Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCTMX Short Interest Over TimeCTMX Days to Cover Over TimeCTMX Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. CytomX Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,600,000 shares $5.87 million +0.3%N/A0.6 $1.63 4/15/20243,590,000 shares $7.07 million +8.1%N/A4 $1.97 3/31/20243,320,000 shares $7.24 million -6.0%N/A3.8 $2.18 3/15/20243,530,000 shares $7.31 million +115.2%N/A4.1 $2.07 2/29/20241,640,000 shares $4.02 million +26.2%N/A2.2 $2.45 2/15/20241,300,000 shares $1.95 million +4.0%N/A2.8 $1.50 Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,250,000 shares $1.91 million -5.3%N/A4.2 $1.53 1/15/20241,320,000 shares $2.28 million -0.8%N/A4.4 $1.73 12/31/20231,330,000 shares $2.06 million +35.5%N/A4.9 $1.55 12/15/2023981,600 shares $1.38 million -26.8%N/A5 $1.41 11/30/20231,340,000 shares $1.86 million +0.8%N/A7.5 $1.39 11/15/20231,330,000 shares $1.72 million +5.6%N/A8 $1.29 10/31/20231,260,000 shares $1.39 million -18.2%N/A7 $1.10 10/15/20231,540,000 shares $1.93 million -9.9%N/A8.5 $1.25 9/30/20231,710,000 shares $2.21 million -23.0%N/A9.5 $1.29 9/15/20232,220,000 shares $3.06 million +2.3%N/A8.2 $1.38 8/31/20232,170,000 shares $3.26 million +5.9%N/A7.5 $1.50 8/15/20232,050,000 shares $3.26 million -21.5%N/A6.5 $1.59 7/31/20232,610,000 shares $4.54 million -3.0%4.0%7 $1.74 7/15/20232,690,000 shares $4.90 million +13.0%4.1%6.8 $1.82 6/30/20232,380,000 shares $4.09 million No Change3.7%5.3 $1.72 6/15/20232,380,000 shares $3.71 million +4.4%3.7%4.5 $1.56 5/31/20232,280,000 shares $3.90 million +7.0%3.5%3.4 $1.71 5/15/20232,130,000 shares $3.88 million -13.4%3.3%2.8 $1.82 4/30/20232,460,000 shares $4.01 million +9.3%3.8%2.8 $1.63 4/15/20232,250,000 shares $3.74 million +40.6%3.5%2 $1.66 3/31/20231,600,000 shares $2.42 million -14.9%2.5%1 $1.51 3/15/20231,880,000 shares $3.82 million +48.0%2.9%0.8 $2.03 2/28/20231,270,000 shares $2.73 million -8.0%2.0%0.5 $2.15 2/15/20231,380,000 shares $3.20 million -13.8%2.1%0.5 $2.32 1/31/20231,600,000 shares $4.32 million -43.3%2.5%0.5 $2.70 1/15/20232,820,000 shares $8.07 million +433.7%4.3%1 $2.86 12/30/2022528,400 shares $845,440.00 -64.1%0.8%0.2 $1.60 12/15/20221,470,000 shares $2.34 million -26.1%2.3%1.1 $1.59 11/30/20221,990,000 shares $3.46 million +103.7%3.1%1.6 $1.74 11/15/2022977,100 shares $1.16 million -2.0%1.5%0.8 $1.19 10/31/2022997,400 shares $1.31 million -6.8%1.6%2 $1.31 10/15/20221,070,000 shares $1.52 million -10.8%1.7%1.6 $1.42 9/30/20221,200,000 shares $1.74 million +2.6%1.9%1.3 $1.45 9/15/20221,170,000 shares $1.94 million +30.9%1.9%0.7 $1.66Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. CTMX Short Interest - Frequently Asked Questions What is CytomX Therapeutics' current short interest? Short interest is the volume of CytomX Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,600,000 shares of CTMX short. Learn More on CytomX Therapeutics' current short interest. What is a good short interest ratio for CytomX Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTMX shares currently have a short interest ratio of 1.0. Learn More on CytomX Therapeutics's short interest ratio. Which institutional investors are shorting CytomX Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CytomX Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is CytomX Therapeutics' short interest increasing or decreasing? CytomX Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,600,000 shares, an increase of 0.3% from the previous total of 3,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CytomX Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CytomX Therapeutics: Skye Bioscience, Inc. (0.29%), CervoMed Inc. (1.06%), I-Mab (1.43%), Renovaro Inc. (2.09%), InterCure Ltd. (0.15%), Repare Therapeutics Inc. (2.38%), Syros Pharmaceuticals, Inc. (7.79%), ProQR Therapeutics (0.41%), scPharmaceuticals Inc. (17.76%), Prelude Therapeutics Incorporated (2.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short CytomX Therapeutics stock? Short selling CTMX is an investing strategy that aims to generate trading profit from CytomX Therapeutics as its price is falling. CTMX shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytomX Therapeutics? A short squeeze for CytomX Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CTMX, which in turn drives the price of the stock up even further. How often is CytomX Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTMX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SKYE Short Interest CRVO Short Interest IMAB Short Interest RENB Short Interest INCR Short Interest RPTX Short Interest SYRS Short Interest PRQR Short Interest SCPH Short Interest PRLD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTMX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe 1,000X Crypto PlaybookTrue Market InsidersWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media